Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four genes that could help diagnose severe alopecia areata early.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Non-immune factors play a significant role in alopecia areata.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Regenerative medicine is effective and safe for treating vitiligo.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Vitamin A affects hair loss and immune response in alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

A patient with lupus experienced a condition where their immune cells became overactive.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.